相关实验视频

Updated: Jul 1, 2025

Ovine Lumbar Intervertebral Disc Degeneration Model Utilizing a Lateral Retroperitoneal Drill Bit Injury

Ovine Lumbar Intervertebral Disc Degeneration Model Utilizing a Lateral Retroperitoneal Drill Bit Injury

Published on: May 25, 2017

从高血糖到椎间盘损伤:探索糖尿病诱导的椎间盘退化

Shuai Li^1,2,3, Jinpeng Du^1,3, Yunfei Huang^1,3

¹Department of Spine Surgery, Honghui Hospital, Xi'an Jiaotong University, Youyidong Road, Xi'an, Shaanxi, China.

Frontiers in immunology

|March 6, 2024

概括

高血糖水平加速椎间盘退化 (IDD),这是腰椎椎间盘的关键因素. 了解这些机制对于开发针对性治疗影响脊柱健康的代谢障碍至关重要.

科学领域:

生物医学科学生物医学科学
整形外科整形外科整形外科
代谢研究研究代谢研究

背景情况:

腰椎间盘的发病率正在上升,造成了严重的患者和社会负担.
椎间盘退化 (IDD) 是主要的原因,受衰老,机械压力和代谢障碍的影响.
高葡萄糖和高脂肪饮食 (HFD) 通过炎症和改变新陈代谢来破坏磁盘平衡.

研究的目的:

系统地审查高血糖症对椎间盘退行症 (IDD) 进展的影响.
探索异常葡萄糖代谢影响IDD的机制.
确定开发高葡萄糖诱导的IDD有效治疗的目标.

主要方法:

系统的文献审查.
对研究高葡萄糖对椎间盘细胞和细胞外基质的影响的分析.
检查包括细胞衰老,细胞亡,细胞亡和ECM降解等途径.

主要成果:

过高血糖会对椎间盘细胞产生不良影响,包括衰老,亡和烧亡.
异常的葡萄糖代谢导致椎间盘中的细胞外基质 (ECM) 退化.
先进的糖化终产品 (AGEs) 的积累与IVD的有害变化有关.

结论:

高血糖症通过各种细胞和分子机制显著加剧椎间盘退化 (IDD).
进一步研究异常葡萄糖代谢在IDD中的作用对于治疗的发展至关重要.
针对高血糖的有针对性的干预措施是必要的,以有效治疗IDD患者.

关键词:

年龄的 AGEs.椎间盘退化椎间盘退化纤维化的圆环.软骨的末端板块软骨的末端板块高葡萄糖的情况.它的核是脉冲的脉冲.

更多相关视频

A Proinflammatory, Degenerative Organ Culture Model to Simulate Early-Stage Intervertebral Disc Disease.

A Proinflammatory, Degenerative Organ Culture Model to Simulate Early-Stage Intervertebral Disc Disease.

Published on: February 14, 2021

Operational and Intervention Effects of Targeted Tuina in Lumbar Intervertebral Disc Degeneration Model Rabbits

Operational and Intervention Effects of Targeted Tuina in Lumbar Intervertebral Disc Degeneration Model Rabbits

Published on: July 21, 2023

相关概念视频

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...